MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Immuno-Oncology, Immunotherapy
GT Biopharma, Inc. (NASDAQ: GTBP)*
Organization & Developments: GT Biopharma
Parents
GT Biopharma, Inc. (NASDAQ: GTBP)*
Children
*GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products based on our proprietary Trispecific Killer Engagers (TriKE™) target-directed Natural Killer (NK) cell engager platform.
*The TriKE™ NK protein biologic platform is designed to harness and amplify the body’s native immune system for hope for patients with cancer and infectious diseases.
GT Biopharma, Inc (NASDAQ: GTBP) is a biopharmaceutical company focused on the development of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform
Jumps
Finance & Acquisitions: GT Biopharma
Key People: GT Biopharma